884 related articles for article (PubMed ID: 33492661)
1. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
Auclair J; Frappier M; Millette M
Clin Infect Dis; 2015 May; 60 Suppl 2():S135-43. PubMed ID: 25922399
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis of the Clostridioides difficile response to a specific lactobacilli probiotic formulation: explanations for its mechanisms of action.
Masset Z; Gunaratnam S; Millette M; McFarland LV; Lacroix M
J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36898672
[TBL] [Abstract][Full Text] [Related]
4. A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
Maziade PJ; Pereira P; Goldstein EJ
Clin Infect Dis; 2015 May; 60 Suppl 2():S144-7. PubMed ID: 25922400
[TBL] [Abstract][Full Text] [Related]
5. Probiotics and prevention of Clostridium difficile infection.
Goldstein EJC; Johnson SJ; Maziade PJ; Evans CT; Sniffen JC; Millette M; McFarland LV
Anaerobe; 2017 Jun; 45():114-119. PubMed ID: 27988389
[TBL] [Abstract][Full Text] [Related]
6. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
McFarland LV; Ship N; Auclair J; Millette M
J Hosp Infect; 2018 Aug; 99(4):443-452. PubMed ID: 29702133
[TBL] [Abstract][Full Text] [Related]
7. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients.
Gao XW; Mubasher M; Fang CY; Reifer C; Miller LE
Am J Gastroenterol; 2010 Jul; 105(7):1636-41. PubMed ID: 20145608
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
Preston K; Krumian R; Hattner J; de Montigny D; Stewart M; Gaddam S
Benef Microbes; 2018 Sep; 9(5):697-706. PubMed ID: 29888656
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells.
Boonma P; Spinler JK; Venable SF; Versalovic J; Tumwasorn S
BMC Microbiol; 2014 Jul; 14():177. PubMed ID: 24989059
[TBL] [Abstract][Full Text] [Related]
10. Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
Bresee LC; Lamont N; Ocampo W; Holroyd-Leduc J; Sabuda D; Leal J; Dalton B; Kaufman J; Missaghi B; Kim J; Larios OE; Henderson E; Raman M; Fletcher JR; Faris P; Kraft S; Shen Y; Louie T; Conly JM
BMC Health Serv Res; 2023 Dec; 23(1):1386. PubMed ID: 38082421
[TBL] [Abstract][Full Text] [Related]
11. Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly.
Lahtinen SJ; Forssten S; Aakko J; Granlund L; Rautonen N; Salminen S; Viitanen M; Ouwehand AC
Age (Dordr); 2012 Feb; 34(1):133-43. PubMed ID: 21264685
[TBL] [Abstract][Full Text] [Related]
12. The synergistic effect of cell wall extracted from probiotic biomass containing Lactobacillus acidophilus CL1285, L. casei LBC80R, and L. rhamnosus CLR2 on the anticancer activity of cranberry juice-HPLC fractions.
Desrouillères K; Millette M; Bagheri L; Maherani B; Jamshidian M; Lacroix M
J Food Biochem; 2020 May; 44(5):e13195. PubMed ID: 32185816
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Bio-K+ for the prevention of
Leal J; Shen Y; Faris P; Dalton B; Sabuda D; Ocampo W; Bresee L; Chow B; Fletcher JR; Henderson E; Kaufman J; Kim J; Raman M; Kraft S; Lamont NC; Larios O; Missaghi B; Holroyd-Leduc J; Louie T; Conly J
Infect Control Hosp Epidemiol; 2024 Apr; 45(4):443-451. PubMed ID: 38073551
[TBL] [Abstract][Full Text] [Related]
14. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.
Maziade PJ; Andriessen JA; Pereira P; Currie B; Goldstein EJ
Curr Med Res Opin; 2013 Oct; 29(10):1341-7. PubMed ID: 23931498
[TBL] [Abstract][Full Text] [Related]
15. [Influence of selected Lactobacillus sp. on Clostridium difficile strains with different toxigenicity profile].
Wultańska D; Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Luczak M
Med Dosw Mikrobiol; 2006; 58(2):127-33. PubMed ID: 17133906
[TBL] [Abstract][Full Text] [Related]
16. Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.
Aroutcheva A; Auclair J; Frappier M; Millette M; Lolans K; de Montigny D; Carrière S; Sokalski S; Trick WE; Weinstein RA
Probiotics Antimicrob Proteins; 2016 Mar; 8(1):31-40. PubMed ID: 26915093
[TBL] [Abstract][Full Text] [Related]
17. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
McFarland LV; Evans CT; Goldstein EJC
Front Med (Lausanne); 2018; 5():124. PubMed ID: 29868585
[TBL] [Abstract][Full Text] [Related]
18. Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains?
Tejero-Sariñena S; Barlow J; Costabile A; Gibson GR; Rowland I
Anaerobe; 2013 Dec; 24():60-5. PubMed ID: 24091275
[TBL] [Abstract][Full Text] [Related]
19. Fermentation adaptability of three probiotic Lactobacillus strains to oat, germinated oat and malted oat substrates.
Herrera-Ponce A; Nevárez-Morillón G; Ortega-Rívas E; Pérez-Vega S; Salmerón I
Lett Appl Microbiol; 2014 Oct; 59(4):449-56. PubMed ID: 24979232
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Toxic Shock Syndrome-Associated
Schlievert PM; Gaitán AV; Kilgore SH; Roe AL; Maukonen J; Lehtoranta L; Leung DYM; Marsman DS
Microbiol Spectr; 2023 Aug; 11(4):e0173523. PubMed ID: 37404182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
